Retraction notices

Exemestane blocks mesothelioma growth through downregulation of cAMP, pCREB and CD44 implicating new treatment option in patients affected by this disease

Type
Retraction
Notice date
12/9/2022 0:00
Journal
Molecular Cancer
Publisher
Springer - Biomed Central (BMC)
Notice DOI
10.1186/s12943-022-01692-9
Original paper DOI
10.1186/1476-4598-13-69

Reasons

Matching venue names

Name match only, not an authoritative journal identifier.